• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对类似问题的随机试验通常在提前因获益而停止后发布。

Randomized trials addressing a similar question are commonly published after a trial stopped early for benefit.

机构信息

Evidence-Based Practice Center, Mayo Clinic, 200, 1st street, Rochester, MN 55905, USA; Knowledge and Evaluation Research Unit, Mayo Clinic, 200, 1st street, Rochester, MN 55905, USA; Division of Preventive Medicine, Mayo Clinic, 200, 1st street, Rochester, MN 55905, USA.

Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario L8S 4L8, Canada.

出版信息

J Clin Epidemiol. 2017 Feb;82:12-19. doi: 10.1016/j.jclinepi.2016.10.006. Epub 2016 Nov 8.

DOI:10.1016/j.jclinepi.2016.10.006
PMID:27832953
Abstract

OBJECTIVE

We explored how investigators of ongoing or planned trials respond to the publication of a trial stopped early for benefit addressing a similar question.

STUDY DESIGN AND SETTING

We searched multiple databases from the date of publication of the truncated trial through August, 2015. Independent reviewers selected trials and extracted data.

RESULTS

We identified 207 trials truncated for early benefit; of which 102 (49%) were followed by subsequent trials (262 subsequent trials, median 2 per truncated trial, range 1-13). Only 99 (38%) provided a rationale justifying conducting a trial despite prior stopping. The top reasons were to address different population or setting (33%), skepticism of truncated trials findings because of small sample size (12%), inconsistency with other evidence (11%), or increased risk of bias (7%). We did not identify significant associations between subsequent trials and characteristics of truncated ones (risk of bias, precision, funding, or rigor of stopping decision).

CONCLUSION

About half of the trials stopped early for benefit were followed by subsequent trials addressing a similar question. This suggests that future trialists may have been skeptic about the decision to stop prior trials. A more rigorous threshold for stopping early for benefit is needed.

摘要

目的

我们探究了正在进行或计划中的试验的研究者如何应对因同样问题而提前停止的试验的发表。

研究设计和设置

我们从截短试验的发表日期到 2015 年 8 月在多个数据库中进行了搜索。独立评审员选择了试验并提取了数据。

结果

我们确定了 207 项因早期获益而截短的试验;其中 102 项(49%)随后进行了后续试验(262 项后续试验,中位数为每个截短试验 2 项,范围 1-13 项)。只有 99 项(38%)提供了一个理由,说明尽管之前已经停止,但仍有必要进行试验。最主要的原因是为了针对不同的人群或环境(33%)、对小样本量的截短试验结果持怀疑态度(12%)、与其他证据不一致(11%)或增加偏倚风险(7%)。我们没有发现后续试验与截短试验的特征(偏倚风险、精度、资金或停止决策的严格性)之间存在显著关联。

结论

约一半因获益而提前停止的试验随后进行了针对类似问题的后续试验。这表明未来的试验设计者可能对先前试验停止的决定持怀疑态度。需要更严格的提前获益停止阈值。

相似文献

1
Randomized trials addressing a similar question are commonly published after a trial stopped early for benefit.针对类似问题的随机试验通常在提前因获益而停止后发布。
J Clin Epidemiol. 2017 Feb;82:12-19. doi: 10.1016/j.jclinepi.2016.10.006. Epub 2016 Nov 8.
2
Randomized trials stopped early for benefit: a systematic review.因有益而提前终止的随机试验:一项系统评价
JAMA. 2005 Nov 2;294(17):2203-9. doi: 10.1001/jama.294.17.2203.
3
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
4
Interventions to improve adherence to inhaled steroids for asthma.改善哮喘患者吸入性糖皮质激素依从性的干预措施。
Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD012226. doi: 10.1002/14651858.CD012226.pub2.
5
Topical antimicrobial agents for treating foot ulcers in people with diabetes.用于治疗糖尿病患者足部溃疡的局部抗菌剂。
Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD011038. doi: 10.1002/14651858.CD011038.pub2.
6
Shared decision-making for people with asthma.哮喘患者的共同决策
Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2.
7
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).纳武单抗用于成人霍奇金淋巴瘤(使用RobotReviewer软件进行的快速综述)
Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen).哌拉西林-他唑巴坦与美罗培南治疗对第三代头孢菌素耐药的肠杆菌科细菌引起的血流感染:一项非劣效性开放标签随机对照试验(PeterPen)的研究方案
BMJ Open. 2021 Feb 8;11(2):e040210. doi: 10.1136/bmjopen-2020-040210.
2
Guidelines for reporting meta-epidemiological methodology research.报告元流行病学方法学研究的指南。
Evid Based Med. 2017 Aug;22(4):139-142. doi: 10.1136/ebmed-2017-110713. Epub 2017 Jul 12.